The stock of Affimed NV (NASDAQ:AFMD) is a huge mover today! About 219,438 shares traded. Affimed NV (NASDAQ:AFMD) has declined 14.40% since August 29, 2016 and is downtrending. It has underperformed by 22.64% the S&P500.The move comes after 6 months positive chart setup for the $94.92M company. It was reported on Apr, 5 by Barchart.com. We have $2.40 PT which if reached, will make NASDAQ:AFMD worth $4.75 million more.
Among 11 analysts covering Arris Group Inc. (NASDAQ:ARRS), 9 have Buy rating, 1 Sell and 1 Hold. Therefore 82% are positive. Arris Group Inc. had 22 analyst reports since July 24, 2015 according to SRatingsIntel. Zacks downgraded ARRIS International plc (NASDAQ:ARRS) on Monday, September 21 to “Sell” rating. The stock of ARRIS International plc (NASDAQ:ARRS) has “Overweight” rating given on Tuesday, September 20 by Morgan Stanley. Jefferies initiated ARRIS International plc (NASDAQ:ARRS) on Friday, June 10 with “Buy” rating. The stock of ARRIS International plc (NASDAQ:ARRS) earned “Buy” rating by Jefferies on Friday, July 29. The rating was initiated by Northland Capital on Tuesday, February 21 with “Market Perform”. The firm has “Buy” rating by Needham given on Thursday, October 29. The firm has “Buy” rating by Drexel Hamilton given on Friday, July 24. The rating was maintained by RBC Capital Markets on Thursday, February 23 with “Outperform”. The firm has “Buy” rating by UBS given on Wednesday, September 9. The firm has “Buy” rating given on Tuesday, March 14 by Goldman Sachs. See ARRIS International plc (NASDAQ:ARRS) latest ratings:
14/03/2017 Broker: Goldman Sachs Old Rating: Neutral New Rating: Buy Old Target: $29.00 New Target: $32.00 Upgrade
23/02/2017 Broker: Needham Rating: Buy Old Target: $35 New Target: $32 Maintain
23/02/2017 Broker: RBC Capital Markets Rating: Outperform Old Target: $35 New Target: $33 Maintain
21/02/2017 Broker: Northland Capital Rating: Market Perform New Target: $30 Initiate
About 841,135 shares traded. ARRIS International plc (NASDAQ:ARRS) has declined 6.91% since August 29, 2016 and is downtrending. It has underperformed by 15.15% the S&P500.
ARRIS International plc is a media entertainment and data communications solutions provider. The company has market cap of $4.98 billion. The Firm operates in two divisions: Customer Premises Equipment , and Network & Cloud (N&C). It has a 303.61 P/E ratio. The Firm enables service providers, including cable, telephone, and digital broadcast satellite operators, and media programmers to deliver media, voice and Internet Protocol (IP) data services to their subscribers.
Investors sentiment increased to 1.5 in 2016 Q4. Its up 1.17, from 0.33 in 2016Q3. It increased, as 1 investors sold ARRIS International plc shares while 1 reduced holdings. 2 funds opened positions while 1 raised stakes. 557,538 shares or 14.36% more from 487,535 shares in 2016Q3 were reported. Gemmer Asset Mngmt Limited Liability Corp holds 0% in ARRIS International plc (NASDAQ:ARRS) or 137 shares. Vantage Investment Advisors Lc reported 2,251 shares stake. 10,680 were reported by Toth Financial Advisory Corp. Moreover, Baxter Bros has 1.65% invested in ARRIS International plc (NASDAQ:ARRS). First Bank & Trust Of Omaha, Nebraska-based fund reported 64,640 shares. Schwartz Investment Counsel holds 310,000 shares or 0.65% of its portfolio.
Affimed N.V. is a clinical-stage biopharmaceutical firm focused on discovering and developing cancer immunotherapies. The company has market cap of $94.92 million. The Company’s product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research that seeks to harness the body’s own immune system to fight tumor cells. It currently has negative earnings. The Company’s pipeline includes FM13, AFM11, AFM21, AFM22, AFM24, TandAb and Trispecific Abs.
